Bevacizumab (B) plus everolimus (E) and panitumumab (P) in refractory advanced solid tumors

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Howard, LA; Bullock, KE; Bendell, JC; Uronis, HE; Vlahovic, G; Blobe, GC; Riedel, RF; Nixon, AB; Gockerman, JP; Hurwitz, HI

Published Date

  • May 20, 2009

Published In

Volume / Issue

  • 27 / 15

International Standard Serial Number (ISSN)

  • 0732-183X